XOMA Co. (NASDAQ:XOMAO) Short Interest Up 3,209.1% in December

XOMA Co. (NASDAQ:XOMAO) was the recipient of a significant increase in short interest in December. As of December 15th, there was short interest totaling 11,615 shares, an increase of 3,209.1% from the November 30th total of 351 shares. Based on an average daily trading volume, of 23,708 shares, the short-interest ratio is currently 0.5 days. Based on an average daily trading volume, of 23,708 shares, the short-interest ratio is currently 0.5 days.

XOMA Stock Up 0.1%

Shares of XOMA stock opened at $25.55 on Thursday. The company has a 50-day moving average of $25.41 and a two-hundred day moving average of $25.43. XOMA has a 12-month low of $23.32 and a 12-month high of $25.76.

XOMA Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be paid a dividend of $0.5234 per share. This represents a $2.09 annualized dividend and a dividend yield of 8.2%. The ex-dividend date of this dividend is Friday, January 2nd.

About XOMA

XOMA Corporation is a clinical-stage biotechnology company specializing in the discovery and development of therapeutic antibodies. The company applies its proprietary protein engineering and antibody optimization platform to generate novel drug candidates targeting autoimmune, inflammatory and metabolic diseases. XOMA’s scientific expertise spans antibody discovery, engineering, in vitro and in vivo testing, and early‐stage clinical development.

In addition to advancing its own pipeline of antibody candidates, XOMA collaborates with pharmaceutical and biotechnology partners to provide research and development services.